Drug Shortage Report for NUCYNTA EXTENDED-RELEASE

Last updated on 2022-12-08 History
Report ID 169640
Drug Identification Number 02415593
Brand name NUCYNTA EXTENDED-RELEASE
Common or Proper name Nucynta
Company Name ENDO VENTURES LTD.
Market Status MARKETED
Active Ingredient(s) TAPENTADOL
Strength(s) 150MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 60 tabs
ATC code N02AX
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-09-20
Estimated end date 2022-11-18
Actual end date 2022-12-07
Shortage status Resolved
Updated date 2022-12-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD
BALLSBRIDGE, DUBLIN
IRELAND D04 H9P8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-12-08 English Compare
v7 2022-12-07 French Compare
v6 2022-12-07 English Compare
v5 2022-11-03 French Compare
v4 2022-11-03 English Compare
v3 2022-09-21 English Compare
v2 2022-09-20 French Compare
v1 2022-09-20 English Compare

Showing 1 to 8 of 8